High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
Epidemiological, clinical, and experimental studies have shown that low levels of plasma high-density lipoprotein cholesterol (HDL-C) are associated with increased atherosclerotic cardiovascular disease (CVD) [...]
Main Authors: | Josep Julve, Joan Carles Escolà-Gil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7488 |
Similar Items
-
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
by: Josep Julve, et al.
Published: (2021-07-01) -
HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01) -
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study
by: Bárbara Fernández-Cidón, et al.
Published: (2021-03-01) -
Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
by: Karin Kornmueller, et al.
Published: (2019-08-01) -
High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
by: Constantine E Kosmas, et al.
Published: (2018-03-01)